Abstract
The steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domain superfamily comprises a diverse group of proteins that bind hydrophobic lipids. The distinguishing feature shared by all members of this family is an α/β helix-grip fold structure containing a long hydrophobic pocket for ligand binding. The mammalian START domain protein family is grouped into 6 subfamilies that bind either cholesterol and oxysterols (STARD1/D3 and STARD4 subfamilies) or phospholipids and sphingolipids (STARD2/D11 subfamily), or have putative functions in Rho-GTPase signaling (STARD8/12/13 subfamily), thioesterase activity (STARD14/15 subfamily), or kinesin motor activity (STARD9). StAR (STARD1) is the namesake of the START domain protein family and has a well-established function in cholesterol transport in the adrenal and gonads for steroid hormone biosynthesis. Some of the mammalian START family members, e.g., STARD1, STARD11, and STARD2 are well characterized for their roles in cholesterol, ceramide, and phosphatidylcholine transfer, respectively, while much remains to be learned about the remaining family members. The purpose of this book is to present a compendium of the history of the discovery and the characterization of the mammalian START proteins, encompassing the seminal work over the past 50 years that has led to our current understanding of these lipid transport proteins. The chapters in this book focus on members of the STARD1/3 and STARD4 subfamilies, which have established roles involved in cholesterol and sterol trafficking. Each chapter provides a personal perspective of the discovery-to-publication journey for work on a START domain family member by authors whose work was instrumental in their discovery and characterization. This introductory chapter provides a brief overview and background on all members of the mammalian START protein family to provide a complete picture of this family of lipid transport proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
NCBI cl14643: SRPBCC is the START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC superfamily. Rho_alpha_C, the C-terminal catalytic domains of the alpha oxygenase subunit of Rieske-type non-heme iron aromatic ring-hydroxylating oxygenases; PIPT, phosphatidylinositol transfer proteins; Bet v 1, the major pollen allergen of white birch, Betula verrucosa; CoxG, carbon monoxide dehydrogenase subunit G (gram-negative bacteria); CalC, and related proteins.
Abbreviations
- ACAT :
-
acyl-CoA:cholesterol acyl transferase
- ACOT :
-
acyl-CoA thioesterase
- BFIT2 :
-
brown fat-inducible thioesterase-2
- CDCA :
-
chenodeoxycholic acid
- CERT :
-
ceramide transfer protein
- COL4A3BP :
-
collagen type IV alpha 3 binding protein
- DLC :
-
deleted in liver cancer
- FFAT :
-
peptide EFFDAxE
- FHA :
-
forkhead-associated phosphopeptide binding domain
- MENTAL :
-
MLN64-N terminal domain
- MLN64 :
-
metastatic axillary lymph node 64 kDa protein
- NPC :
-
Niemann –Pick type C disease
- PC :
-
phosphatidylcholine
- PCTP :
-
phosphatidylcholine transfer protein
- PH :
-
pleckstrin homology domain
- SAM :
-
sterile alpha domain
- SREBP-2 :
-
sterol regulatory element binding protein-2
- StAR :
-
steroidogenic acute regulatory protein
- START :
-
StAR-related lipid transfer domain
References
Ponting CP, Aravind L. START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. Trends Biochem Sci. 1999;24:130–2.
Iyer LM, Koonin EV, Aravind L. Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins. 2001;43:134–44.
Baker BY, Yaworsky DC, Miller WL. A pH-dependent molten globule transition is required for activity of the steroidogenic acute regulatory protein, StAR. J Biol Chem. 2005;280:41753–60.
Bose HS, Whittal RM, Ran Y, Bose M, Baker BY, Miller WL. StAR-like activity and molten globule behavior of StARD6, a male germ-line protein. Biochemistry. 2008;47:2277–88.
Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Lu S, Marchler GH, Mullokandov M, Song JS, Tasneem A, Thanki N, Yamashita RA, Zhang D, Zhang N, Bryant S. CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res. 2009;37:D205–10.
Schrick K, Nguyen D, Karlowski WM, Mayer KF. START lipid/sterol-binding domains are amplified in plants and are predominantly associated with homeodomain transcription factors. Genome Biol. 2004;5:R41.
Soccio RE, Adams RM, Romanowski MJ, Sehayek E, Burley SK, Breslow JL. The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc Natl Acad Sci U S A. 2002;99:6943–8.
Romanowski MJ, Soccio RE, Breslow JL, Burley S. Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain. Proc Natl Acad Sci U S A. 2002;99:6949–54.
Tsujishita Y, Hurley JH. Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol. 2000;7:408–14.
Kudo N, Kumagai K, Matsubara R, Kobayashi S, Hanada K, Wakatsuki S, Kato R. Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer. J Mol Biol. 2010;396:245–51.
Kudo N, Kumagai K, Tomishige N, Yamaji T, Wakatsuki S, Nishijima M, Hanada K, Kato R. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A. 2008;105:488–93.
Roderick SL, Chan WW, Agate DS, Olsen LR, Vetting MW, Rajashankar KR, Cohen DE. Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nat Struct Biol. 2002;9:507–11.
Thorsell AG, Lee WH, Persson C, Siponen MI, Nilsson M, Busam RD, Kotenyova T, Schuler H, Lehtio L. Comparative structural analysis of lipid binding START domains. PLoS One. 2011;6:e19521.
Clark BJ. The mammalian START domain protein family in lipid transport in health and disease. J Endocrinol. 2012;212:257–75.
Alpy F, Tomasetto C. START ships lipids across interorganelle space. Biochimie. 2013;96:85–95.
Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994;269:28314–22.
Moog-Lutz C, Tomasetto C, Regnier CH, Wendling C, Lutz Y, Muller D, Chenard MP, Basset P, Rio MC. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer. 1997;71:183–91.
Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11–q21.3 region of chromosome 17. Genomics. 1995;28:367–76.
Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Ann Rev Physiol. 2001;63:193–213.
Sugawara T, Lin D, Holt JA, Martin KO, Javitt NB, Miller WL, Strauss JF, 3rd. Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry. 1995;34:12506–12.
Rosenbaum AI, Maxfield FR. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J Neurochem. 2011;116:789–95.
Alpy F, Tomasetto C. MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochem Soc Trans. 2006;34:343–5.
Alpy F, Latchumanan VK, Kedinger V, Janoshazi A, Thiele C, Wendling C, Rio MC, Tomasetto C. Functional characterization of the MENTAL domain. J Biol Chem. 2005;280:17945–52.
Charman M, Kennedy BE, Osborne N, Karten B. MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. J Lipid Res. 2009;51:1023–34.
Alpy F, Rousseau A, Schwab Y, Legueux F, Stoll I, Wendling C, Spiegelhalter C, Kessler P, Mathelin C, Rio MC, Levine TP, Tomasetto C. STARD3/STARD3NL and VAP make a novel molecular tether between late endosomes and the ER. J Cell Sci. 2013;126:5500–12.
Chen Y-C, Meier RK, Zheng S, Khundmiri SJ, Tseng MT, Lederer ED, Epstein PN, Clark BJ. Steroidogenic Acute Regulatory (StAR)-Related Lipid Transfer Domain Protein 5 (STARD5) localization and regulation in renal tubules. Am J Physiol Renal Physiol. 2009;297:F380–8. doi:90433.92008.
Mesmin B, Pipalia NH, Lund FW, Ramlall TF, Sokolov A, Eliezer D, Maxfield FR. STARD4 abundance regulates sterol transport and sensing. Mol Biol Cell. 2011;22:4004–15. doi:10.1091/mbc.E11-04-0372.
Rodriguez-Agudo D, Calderon-Dominguez M, Ren S, Marques D, Redford K, Medina-Torres MA, Hylemon P, Gil G, Pandak WM. Subcellular localization and regulation of StarD4 protein in macrophages and fibroblasts. Biochim Biophys Acta. 2011;1811:597–606.
Rodriguez-Agudo D, Ren S, Wong E, Marques D, Redford K, Gil G, Hylemon P, Pandak WM. Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J Lipid Res. 2008;49:1409–19.
Letourneau D, Lorin A, Lefebvre A, Frappier V, Gaudreault F, Najmanovich R, Lavigne P, LeHoux JG. StAR-related lipid transfer domain protein 5 binds primary bile acids. J Lipid Res. 2012;53:2677–89.
Rodriguez-Agudo D, Ren S, Hylemon PB, Redford K, Natarajan R, Del Castillo A, Gil G, Pandak WM. Human StarD5, a cytosolic StAR-related lipid binding protein. J Lipid Res. 2005;46:1615–23.
Borthwick F, Allen AM, Taylor JM, Graham A. Overexpression of STARD3 in human monocyte/macrophages induces an anti-atherogenic lipid phenotype. Clin Sci (Lond). 2010;119:265–72.
Gomes C, Oh SD, Kim JW, Chun SY, Lee K, Kwon HB, Soh J. Expression of the putative sterol binding protein Stard6 gene is male germ cell specific. Biol Reprod. 2005;72:651–8.
Golas A, Malek P, Piasecka M, Styrna J. Sperm mitochondria diaphorase activity-a gene mapping study of recombinant inbred strains of mice. Int J Dev Biol. 2010;54:667–73.
van Helvoort A, de Brouwer, Elferink RP, Borst P. Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces. Proc Natl Acad Sci U S A. 1999;96:11501–6.
Scapa EF, Pocai A, Wu MK, Gutierrez-Juarez R, Glenz L, Kanno K, Li H, Biddinger S, Jelicks LA, Rossetti L, Cohen DE. Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2. FASEB J. 2008;22:2579–90.
Shishova EY, Stoll JM, Ersoy BA, Shrestha S, Scapa EF, Li Y, Niepel MW, Su Y, Jelicks LA, Stahl GL, Glicksman MA, Gutierrez-Juarez R, Cuny GD, Cohen DE. Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology. 2011;54:664–74.
Durand S, Angeletti S, Genti-Raimondi S. GTT1/StarD7, a novel phosphatidylcholine transfer protein-like highly expressed in gestational trophoblastic tumour: cloning and characterization. Placenta. 2004;25:37–44.
Horibata Y, Sugimoto H. StarD7 mediates the intracellular trafficking of phosphatidylcholine to mitochondria. J Biol Chem. 2010;285:7358–65.
Olayioye MA, Hoffmann P, Pomorski T, Armes J, Simpson RJ, Kemp BE, Lindeman GJ, Visvader JE. The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation. Cancer Res. 2004;64:3538–44.
Yamanaka M, Koga M, Tanaka H, Nakamura Y, Ohta H, Yomogida K, Tsuchida J, Iguchi N, Nojima H, Nozaki M, Matsumiya K, Okuyama A, Toshimori K, Nishimune Y. Molecular cloning and characterization of phosphatidylcholine transfer protein-like protein gene expressed in murine haploid germ cells. Biol Reprod. 2000;62:1694–1701.
Ito M, Yamanashi Y, Toyoda Y, Izumi-Nakaseko H, Oda S, Sugiyama A, Kuroda M, Suzuki H, Takada T, Adachi-Akahane S. Disruption of Stard10 gene alters the PPARα-mediated bile acid homeostasis. Biochim Biophys Acta (BBA)—Mol Cell Biol Lipids. 2013;1831:459–68.
Olayioye MA, Vehring S, Muller P, Herrmann A, Schiller J, Thiele C, Lindeman GJ, Visvader JE, Pomorski T. StarD10, a START domain protein overexpressed in breast cancer, functions as a phospholipid transfer protein. J Biol Chem. 2005;280:27436–42.
Olayioye MA, Buchholz M, Schmid S, Schoffler P, Hoffmann P, Pomorski T. Phosphorylation of StarD10 on serine 284 by casein kinase II modulates its lipid transfer activity. J Biol Chem. 2007;282:22492–8.
Murphy NC, Biankin AV, Millar EK, McNeil CM, O’Toole SA, Segara D, Crea P, Olayioye MA, Lee CS, Fox SB, Morey AL, Christie M, Musgrove EA, Daly RJ, Lindeman GJ, Henshall SM, Visvader JE, Sutherland RL. Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status. Int J Cancer. 2009;126:1445–53.
Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 2003;426:803–9.
Hanada K, Kumagai K, Tomishige N, Yamaji T. CERT-mediated trafficking of ceramide. Biochim Biophys Acta. 2009;1791:684–91.
Kang HW, Wei J, Cohen DE. PC-TP/StARD2: of membranes and metabolism. Trends Endocrinol Metab. 2010;21:449–56.
Mencarelli C, Losen M, Hammels C, De Vry J, Hesselink MK, Steinbusch HW, De Baets MH, Martinez-Martinez P. The ceramide transporter and the Goodpasture antigen binding protein: one protein-one function? J Neurochem. 2010;113:1369–86.
Kanno K, Wu MK, Scapa EF, Roderick SL, Cohen DE. Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2. Biochim Biophys Acta. 2007;1771:654–62.
Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res. 1998;58:2196–9.
Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem. 2003;278:10824–30.
Durkin ME, Ullmannova V, Guan M, Popescu NC. Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth. Oncogene. 2007;26:4580–9.
Kim TY, Healy KD, Der CJ, Sciaky N, Bang YJ, Juliano RL. Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration. J Biol Chem. 2008;283:32762–70.
Yamaga M, Sekimata M, Fujii M, Kawai K, Kamata H, Hirata H, Homma Y, Yagisawa H. A PLCdelta1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization. Genes Cells. 2004;9:25–37.
Durkin ME, Yuan BZ, Zhou X, Zimonjic DB, Lowy DR, Thorgeirsson SS, Popescu NC. DLC-1: a Rho GTPase-activating protein and tumour suppressor. J Cell Mol Med. 2007;11:1185–207.
Artemenko IP, Zhao D, Hales DB, Hales KH, Jefcoate CR. Mitochondrial processing of newly synthesized steroidogenic acute regulatory protein (StAR), but not total StAR, mediates cholesterol transfer to cytochrome P450 side chain cleavage enzyme in adrenal cells. J Biol Chem. 2001;276:46583–96.
Hunt MC, Yamada J, Maltais LJ, Wright MW, Podesta EJ, Alexson S. A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. J Lipid Res. 2005;46:2029–32.
Kirkby B, Roman N, Kobe B, Kellie S, Forwood JK. Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog Lipid Res. 2010;49:366–77.
Adams SH, Chui C, Schilbach SL, Yu XX, Goddard AD, Grimaldi JC, Lee J, Dowd P, Colman S, Lewin DA. BFIT, a unique acyl-CoA thioesterase induced in thermogenic brown adipose tissue: cloning, organization of the human gene and assessment of a potential link to obesity. Biochem J. 2001;360:135–42.
Suematsu N, Isohashi F. Molecular cloning and functional expression of human cytosolic acetyl-CoA hydrolase. Acta Biochim Pol. 2006;53:553–61.
Suematsu N, Okamoto K, Isohashi F. Mouse cytosolic acetyl-CoA hydrolase, a novel candidate for a key enzyme involved in fat metabolism: cDNA cloning, sequencing and functional expression. Acta Biochim Pol. 2002;49:937–45.
Suematsu N, Okamoto K, Shibata K, Nakanishi Y, Isohashi F. Molecular cloning and functional expression of rat liver cytosolic acetyl-CoA hydrolase. Eur J Biochem. 2001;268:2700–9.
Alpy F, Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J Cell Sci. 2005;118:2791–801.
Soccio RE, Breslow JL. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J Biol Chem. 2003;278:22183–6.
Torres Jorge Z, Summers Matthew K, Peterson D, Brauer Matthew J, Lee J, Senese S, Gholkar Ankur A, Lo Y-C, Lei X, Jung K, Anderson David C, Davis David P, Belmont L, Jackson Peter K. The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assembly. Cell. 2011;147:1309–23.
Lev S. Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nat Rev Mol Cell Biol. 2010;11:739–50.
Prinz WA. Non-vesicular sterol transport in cells. Prog Lipid Res. 2007;46:297–314.
Strauss JF, 3rd, Kishida T, Christenson LK, Fujimoto T, Hiroi H. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol Cell Endocrinol. 2003;202:59–65.
Barbar E, Lehoux JG, Lavigne P. Toward the NMR structure of StAR. Mol Cell Endocrinol. 2009;300:89–93.
Bose M, Whittal RM, Miller WL, Bose HS. Steroidogenic activity of StAR requires contact with mitochondrial VDAC1 and phosphate carrier protein. J Biol Chem. 2008;283:8837–45.
Murcia M, Faraldo-Gomez JD, Maxfield FR, Roux B. Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol. J Lipid Res. 2006;47:2614–30.
Lorin A, Letourneau D, Lefebvre A, LeHoux JG, Lavigne P. (1)H, (13)C, and (15)N backbone chemical shift assignments of StAR-related lipid transfer domain protein 5 (STARD5). Biomol NMR Assign. 2013;7:21–4.
Soccio RE, Adams RM, Maxwell KN, Breslow JL. Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins: activation of StARD4 by sterol regulatory element-binding protein-2 and StARD5 by endoplasmic reticulum stress. J Biol Chem. 2005;280:19410–8.
Rodriguez-Agudo D, Calderon-Dominguez M, Medina MA, Ren S, Gil G, Pandak WM. ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes. J Lipid Res. 2012;53:2708–15.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Clark, B., Stocco, D. (2014). An Introduction to the Steroidogenic Acute Regulatory Protein (StAR)-Related Lipid Transfer Domain Protein Family. In: Clark, B., Stocco, D. (eds) Cholesterol Transporters of the START Domain Protein Family in Health and Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1112-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1112-7_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1111-0
Online ISBN: 978-1-4939-1112-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)